Pre-market hot trades in US stocks: GeoVax Labs pre-market down 8.31%; Firefly Aerospace pre-market up 8.30%

Pre-market Hot Trades in US Stocks

GeoVax Labs pre-market down 8.31%. Based on recent key news:

1. On May 18, GeoVax Labs raised approximately $2.7 million through a private placement. The company stated that its current cash and cash equivalents are expected to support operations until August 2026. This move has intensified market concerns about the company's financial condition, putting pressure on the stock price.

2. Recently, GeoVax Labs significantly increased the number of shares outstanding, weakening market expectations for its stock price increase. According to Koyfin data, the company currently has 2.89 million shares outstanding, resulting in a stock price decline of over 22% year-to-date in 2026.

3. Despite the stock price decline, retail investor sentiment remains extremely bullish, with a high volume of information. However, some users have indicated that due to the company's substantial increase in shares outstanding, any chance of a rebound has "disappeared." Market doubts about the company's financial condition continue to pressure the stock price.

Firefly Aerospace pre-market up 8.30%. Based on recent key news:

1. On May 26, Firefly Aerospace announced the launch of an initial public offering, planning to issue 4 million shares and sell 8 million shares provided by shareholders, leading to a 4.9% decline in the stock price after hours. Source: MT Newswires

2. On May 26, NASA awarded Firefly Aerospace a $75 million contract for lunar missions, boosting market confidence in its future growth. Source: Public Technologies

3. On May 26, SpaceX submitted IPO documents, igniting market enthusiasm for the space industry and driving up Firefly Aerospace's stock price. Source: Bloomberg's rising interest in the space industry has increased investor attention.

Top Gainers in Pre-market US Stocks

Soligenix pre-market up 104.33%. Based on recent key news:

1. On May 26, Soligenix announced the collection of key data regarding thermal stability, immunogenicity, and similar viral potency. This advancement provides a fast track for vaccine development, significantly boosting the stock price. The company plans to use this information to accelerate the vaccine development process. Source: PR Newswire

2. On May 26, Soligenix was listed on NASDAQ under the ticker symbol SNGX. The company is committed to advancing vaccine development using new data, and the market is optimistic about its prospects, leading to a significant rise in stock price. Source: PR Newswire The biopharmaceutical industry has recently performed strongly, with noticeable capital inflows.

Founder pre-market up 83.51%, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, this stock shows significant volatility, and specific reasons need further observation Nanoviricides pre-market rose 43.71%. There has been no significant news recently; trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. no_news